EMN vs CBT

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 11, 2026

EMN

34.9
AI Score
VS
EMN Wins

CBT

45.9
AI Score

Investment Advisor Scores

EMN

35score
Recommendation
SELL

CBT

46score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric EMN CBT Winner
Forward P/E 9.4162 10.6157 EMN
PEG Ratio 0.5259 1.0017 EMN
Revenue Growth 9.9% 6.4% EMN
Earnings Growth 32.5% -93.7% EMN
Tradestie Score 34.9/100 45.9/100 CBT
Profit Margin 5.0% 5.2% CBT
Beta 1.00 1.00 Tie
AI Recommendation SELL HOLD CBT

Relative Price Performance (Last 90 Days)

EMN 1M: -6.1% · 3M: -7.1% CBT 1M: -7.7% · 3M: -6.8%

Current Technical Phase

EMN

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 37

RSI (14): 37.5 · Price: $68.11

CBT

Markdown
Sell / avoid

Price below a falling SMA50 (slope -2.1%), weak momentum, RSI 38

RSI (14): 37.7 · Price: $79.68

Fundamentals Snapshot

Metric EMN CBT
Market Cap
Forward P/E 9.8 11.4
Trailing P/E 17.8 22.2
Revenue (TTM)
Revenue Growth 0.1% 0.1%
Gross Margin 0.2% 0.2%
Operating Margin 0.1% 0.1%
EPS 3.84 3.55
Dividend Yield 0.05% 0.02%

Frequently Asked Questions

Based on our detailed analysis, EMN is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.